Atea Pharmaceuticals, Inc. (AVIR)
4.67
-0.06
(-1.27%)
USD |
NASDAQ |
May 29, 16:00
4.66
-0.01
(-0.21%)
After-Hours: 20:00
Atea Pharmaceuticals Total Liabilities (Quarterly) : 33.37M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 40.23M |
| CorMedix, Inc. | 378.59M |
| Eloxx Pharmaceuticals, Inc. | 16.09M |
| Cannabis Global, Inc. | 6.178M |
| Breakthrough Chemistry, Inc. | 0.4138M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 267.08M |
| Shareholders Equity (Quarterly) | 233.71M |
| Debt to Equity Ratio | 0.0027 |
| Current Ratio | 7.888 |
| Net Debt Paydown Yield | 0.05% |